NCT02806895View on ClinicalTrials.gov

Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 5, 2016

Primary Completion Date

May 28, 2019

Study Completion Date

May 28, 2019

Conditions
Obstructive Sleep ApneaExcessive Sleepiness
Interventions
DRUG

JZP-110

DRUG

Placebo

Trial Locations (1)

6229

Maastricht University, Maastricht

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY